| Ex Vivo Cultured Bone Marrow Derived Allogenic MSCs in AMI (NCT00883727) | Stempeutics Research Pvt Ltd | 2009-04-01 |
| Study Of Axitinib In Combination With Cisplatin And Capecitabine In Patients With Advanced Gastric Cancer (NCT00842244) | Pfizer | 2009-04-01 |
| Ph I/II of Vitamin D on Bone Mineral Density & Markers of Bone Resorption (NCT00904423) | Mark Pegram | 2009-04-01 |
| "Safety, Tolerability and Pharmacokinetics of MP-376 Administered for 14 Days to Stable Pediatric (CF) Patients" (NCT00840333) | Amgen | 2009-04-01 |
| A Study to Evaluate the Effect of Ketoconazole and Rifampicin on the Pharmacokinetics of Fimasartan in Healthy Male Volunteers (NCT00938262) | Boryung Pharmaceutical Co., Ltd | 2009-04-01 |
| Comparative Safety Study of New Sinecort Formulation Versus Positive Control (NCT00885937) | Bayer | 2009-04-01 |
| Mesenchymal Stem Cells in Critical Limb Ischemia (NCT00883870) | Stempeutics Research Pvt Ltd | 2009-04-01 |
| A Study in Healthy Adult Subjects to Evaluate the Safety, Tolerability, and Pharmacokinetic Profiles of Multiple Doses of ABT-072 Used to Treat Hepatitis C (NCT00890318) | Abbott | 2009-04-01 |
| Phase I Trial of Oral Metronomic Topotecan and Oral Pazopanib to Treat Recurrent/Persistent Gynecologic Tumors (NCT00800345) | Vector Oncology | 2009-04-01 |
| Staccato Loxapine Thorough QT/QTc Study (NCT00874237) | Nova Pneuma Inc. | 2009-04-01 |
| Pharmacokinetic Study of the Penetration of Ceftobiprole in the Bone (NCT00771524) | Basilea Pharmaceutica | 2009-04-01 |
| Intensity-Modulated Radiation Therapy and Gemcitabine in Treating Patients With Locally Advanced Pancreatic Cancer (NCT00878657) | Rutgers, The State University of New Jersey | 2009-04-01 |
| Esomeprazole Bioavailability Study With 40 mg Oral Single Dose Fasted and Fed Administration (NCT00889850) | Mepha Ltd. | 2009-04-01 |
| Interaction Between Reboxetine and 3,4-Methylenedioxymethamphetamine: Pharmacodynamics (PD) and Pharmacokinetics (PK) (NCT00886886) | University Hospital, Basel, Switzerland | 2009-04-01 |
| Combination of Sorafenib and Vorinostat in Poor-risk Acute Myelogenous Leukemia (AML) and High Risk Myelodysplastic Syndrome (MDS) (NCT00875745) | Indiana University | 2009-04-01 |
| Study of Erlotinib in Combination With Bortezomib (NCT00895687) | M.D. Anderson Cancer Center | 2009-04-01 |
| Study Evaluating The Potential Effect Of Rifampin On The Pharmacokinetics Of Neratinib (NCT00864487) | Puma Biotechnology, Inc. | 2009-04-01 |
| Extracorporal Photopheresis Pilot Study (NCT00930566) | Hospices Civils de Lyon | 2009-04-01 |
| BG9928 in Subjects With Hepatic Impairment (NCT00858156) | Biogen | 2009-04-01 |
| Trial of High Dose Topotecan With Carboplatin in Patients With Relapsed Ovarian Carcinoma (NCT01177501) | Assistance Publique - Hôpitaux de Paris | 2009-04-01 |
| Study Evaluating The PK And Safety Of Neratinib In Healthy Subjects And Subjects With Chronic Liver Disease (NCT00781430) | Puma Biotechnology, Inc. | 2009-04-01 |
| Multiple Dose Study To Investigate The Effects Of Fesoterodine And Solifenacin On Gastrointestinal Transit (NCT00832650) | Pfizer | 2009-04-01 |
| An Open Label Positron Emission Tomography (PET) Study to Determine Central mGluR5 Receptor Occupancy of AZD2516 (NCT00892944) | AstraZeneca | 2009-04-01 |
| Mesenchymal Stem Cells in a Clinical Trial to Heal Articular Cartilage Defects (NCT00885729) | University Hospital, Akershus | 2009-04-01 |
| Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Cord Blood Transplant for Hematologic Malignancy (NCT00891137) | Cellerant Therapeutics | 2009-04-01 |
| A Study in Type 1 Gaucher Patients to Evaluate the Pharmacokinetics, Safety and Pharmacodynamics of AT2101 (NCT00875160) | Amicus Therapeutics | 2009-04-01 |
| Yttrium Y 90 Glass Microspheres and Capecitabine in Treating Patients With Liver Cholangiocarcinoma or Liver Metastases (NCT00858429) | Northwestern University | 2009-04-01 |
| A Pharmacokinetic And Safety Study Of Voriconazole In Healthy Male And Female Adults (NCT00855101) | Pfizer | 2009-04-01 |
| Prebiotics and Immune Function in Middle Aged Humans (NCT00898599) | University Hospital Southampton NHS Foundation Trust | 2009-04-01 |
| Designing and Testing a Family Therapy for Adolescent Depression (NCT00867919) | Oregon Research Institute | 2009-04-01 |
| Phase I Multiple Ascending Dose Study for AZD 7268 in Healthy Volunteers (NCT00861718) | AstraZeneca | 2009-04-01 |
| Fludeoxyglucose F 18-PET/CT Scans in Patients Receiving Ultra Short-Term Dexamethasone For Lung Nodules (NCT00906503) | Barbara Ann Karmanos Cancer Institute | 2009-04-01 |
| A First In Human Study To Evaluate The Safety, Tolerability And Pharmacokinetics Of PF-04455242 In Single Rising Doses In Healthy Adult Volunteers (NCT00938301) | Pfizer | 2009-04-01 |
| Clinical Pharmacology Study of AZD7295 in Healthy Subjects (NCT00906256) | Arrow Therapeutics | 2009-04-01 |
| An Open Label Study of the Effects of Eculizumab in Neuromyelitis Optica (NCT00904826) | Mayo Clinic | 2009-04-01 |
| Study Evaluating The Co-Administration Of Moxidectin And Midazolam In Healthy Subjects (NCT00856362) | Wyeth is now a wholly owned subsidiary of Pfizer | 2009-04-01 |
| Middle School Physical Activity Intervention for Girls (NCT01351649) | Michigan State University | 2009-04-01 |
| Nifedipine Bioavailability Study With Oral Single Doses Under Fasting and Fed Conditions (NCT00884442) | SocraTec R&D GmbH | 2009-04-01 |
| Pharmacodynamic and Pharmacokinetic Study of 2 Different Dose Regimen of Clopidogrel in CYP2C19 Genotyped Healthy Subjects (NCT01123824) | Sanofi | 2009-04-01 |
| Higher Protein Diet and Exercise for Optimal Weight Loss in Elderly Women (NCT00912210) | University of Illinois at Urbana-Champaign | 2009-04-01 |
| Bendamustine With Irinotecan Followed by Etoposide/Carboplatin for Patients With Extensive Stage Small Cell Lung Cancer (NCT00856830) | University of Alabama at Birmingham | 2009-04-01 |
| A Study To Investigate Safety, Tolerability, And Pharmacokinetics Of PF-00868554 In Japanese Healthy Adult Volunteers (NCT00875628) | Pfizer | 2009-04-01 |
| A Study of the Pharmacology of Oseltamivir (Tamiflu) in Pregnancy (NCT00873886) | University of Pittsburgh | 2009-04-01 |
| DWP05195 in Healthy Adult Male Volunteers (NCT00969787) | Daewoong Pharmaceutical Co. LTD. | 2009-04-01 |
| Staccato Loxapine PK in Smokers and Nonsmokers (NCT00873769) | Alexza Pharmaceuticals, Inc. | 2009-04-01 |
| Panobinostat/Velcade in Multiple Myeloma (NCT00891033) | University of Arkansas | 2009-04-01 |
| Bioavailability of Combination Tablet BI 1356/Metformin Compared With Single BI 1356 and Metformin Administered Together to Healthy Male and Female Subjects (NCT02173639) | Boehringer Ingelheim | 2009-04-01 |
| Study of EC0489 for the Treatment of Refractory or Metastatic Tumors (NCT00852189) | Endocyte | 2009-04-01 |
| Reproducibility of Child-Turcotte-Pugh (CTP) Rating and NRL972 Pharmacokinetics in Patients With Cirrhosis (NCT00896597) | Norgine | 2009-04-01 |
| Safety and Tolerability Study of APN01 (Recombinant Human Angiotensin Converting Enzyme 2) (NCT00886353) | Apeiron Biologics | 2009-04-01 |
| Drug-Drug Interaction (DDI) w/Ketoconazole or Fluconazole (NCT00860275) | Bristol-Myers Squibb | 2009-04-01 |
| A Study To Assess The Effect Of PF-03893787 On Lung Function Following An Allergen Challenge In Asthmatic Subjects (NCT00856687) | Pfizer | 2009-04-01 |
| Initiating Transdermal Estradiol Therapy in Turner's Syndrome (NCT00870220) | University of Chicago | 2009-04-01 |
| Intratumoral Poly-ICLC Plus Low Dose Local Radiation in Low Grade Recurrent B and T Cell Lymphoma (NCT00880867) | Nevada Cancer Institute | 2009-04-01 |
| To Evaluate Whether Acetyl Salicylic Acid (Aspirin), the Combination of Aspirin and Clopidogrel and Darexaban (YM150) Interact in Their Effects (NCT01409616) | Astellas Pharma Inc | 2009-04-01 |
| A Study of LY2405319 in Participants With Type 2 Diabetes (NCT01869959) | Eli Lilly and Company | 2009-04-01 |
| Preoperative Hyperthermia in Major Abdominal Surgery Patients (NCT00876954) | Medical University of Vienna | 2009-04-01 |
| EMD 521873 Plus Radiotherapy in Non Small Cell Lung Cancer (NSCLC) (NCT00879866) | Merck KGaA, Darmstadt, Germany | 2009-04-01 |
| GDC-0449 and Erlotinib Hydrochloride With or Without Gemcitabine Hydrochloride in Treating Patients With Metastatic Pancreatic Cancer or Solid Tumors That Cannot Be Removed by Surgery (NCT00878163) | National Cancer Institute (NCI) | 2009-03-31 |
| The Relationship Between Uric Acid and Inflammatory Markers (NCT01323335) | National Institute on Aging (NIA) | 2009-03-31 |
| A Phase 1, Dose Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Intravenous Dimethane Sulfonate (DMS612) in Advanced Malignancies (NCT00923520) | National Cancer Institute (NCI) | 2009-03-25 |
| Tafenoquine/Chloroquine DDI Study (NCT00871156) | GlaxoSmithKline | 2009-03-24 |
| Clinical Study to Assess the Pharmacokinetics, Safety and Tolerability of SRT2104 Administered to Normal Healthy Male Volunteers (NCT00933062) | GlaxoSmithKline | 2009-03-23 |
| Study Evaluating Brompheniramine Maleate Liquid in Children and Adolescents (NCT00894634) | Wyeth is now a wholly owned subsidiary of Pfizer | 2009-03-21 |
| A Study to Demonstrate the Safety and Preliminary Efficacy of 18F-FLT in Patients With Solid Tumours or Lymphoma (NCT01065805) | AHS Cancer Control Alberta | 2009-03-20 |
| VEG111485: A QTc Study of Pazopanib (NCT00861029) | GlaxoSmithKline | 2009-03-19 |
| A Phase I Study of MK-2206 in Combination With Standard Chemotherapy in Participants With Locally Advanced or Metastatic Solid Tumors (MK-2206-003) (NCT00848718) | Merck Sharp & Dohme LLC | 2009-03-17 |
| Repeat Dose Safety Study for Compound to Treat Anemia (NCT00840320) | GlaxoSmithKline | 2009-03-13 |
| An Open Label Phase I Study to Eval the Safety and Tolerability of a Vaccine (GI-6207) Consisting of Whole, Heat-killed Recombinant Saccharomyces Cerevisiae (Yeast) Genetically Modified to Express CEA Protein in Adults With Metastatic CEA-expressing ... (NCT00924092) | National Cancer Institute (NCI) | 2009-03-13 |
| Study to Assess the Safety of a New GSK Biologicals' GSK2231395A Candidate Vaccine (NCT00849069) | GlaxoSmithKline | 2009-03-12 |
| Ursodiol, Combination Chemotherapy, and Bevacizumab in Treating Patients With Stage IV Colorectal Cancer (NCT00873275) | City of Hope Medical Center | 2009-03-11 |
| Adjuvant Therapy of Pegylated Interferon- 2b Plus Melanoma Peptide Vaccine (NCT00861406) | M.D. Anderson Cancer Center | 2009-03-10 |
| A Study to Examine the Effects of Esomeprazole on the Pharmacokinetics of Orally Administered Lapatinib in Subjects With Metastatic ErbB2 Positive Breast Cancer (NCT00849329) | GlaxoSmithKline | 2009-03-10 |
| A Dose-escalation Study to Evaluate the Safety, Tolerability, and Antitumor Activity of MEDI-573 in Subjects With Advanced Solid Tumors (NCT00816361) | MedImmune LLC | 2009-03-09 |
| Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer (NCT00807859) | Amgen | 2009-03-09 |
| A Study to Examine the Effects of Low and High-fat Meals on Orally Administered Lapatinib in Metastatic ErbB2 Positive Breast Cancer Patients (NCT00821054) | GlaxoSmithKline | 2009-03-06 |
| Concurrent Adjuvant Carboplatin and Accelerated Radiotherapy for Triple Negative Breast Cancer (NCT01289353) | NYU Langone Health | 2009-03-06 |
| A Pilot Study of the Safety and Activity of Escalating Doses of ON 01910.Na in Patients With Relapsed Mantle Cell Lymphoma, Multiple Myeloma, Chronic Lymphocytic Leukemia, and Related Lymphoid Malignancies (NCT00861510) | National Heart, Lung, and Blood Institute (NHLBI) | 2009-03-05 |
| VRC 307: A Double-Blind, Randomized Phase I Study of the Safety and Immunogenicity of a Prime-Boost Schedule of the Investigational DNA Trivalent Influenza Vaccine, VRC-FLUDNA047-00-VP, Followed by the 2008/2009 Seasonal Influenza Trivalent Inactivat... (NCT00858611) | National Institute of Allergy and Infectious Diseases (NIAID) | 2009-03-03 |
| A Dose Escalation, Dose Expansion Study to Evaluate the Safety, Tolerability, and Antitumor Activity of MEDI-575, in Subjects With Advanced Tumors. (NCT00816400) | MedImmune LLC | 2009-03-02 |
| A Phase 1 Study of IXAZOMIB in Adult Patients With Advanced Nonhematologic Malignancies (NCT00830869) | Millennium Pharmaceuticals, Inc. | 2009-03-02 |
| Phase 1/2 Study of Metastatic Renal Cancer Using T-Cells Transduced With a T-Cell Receptor Which Recognizes TRAIL Bound to the DR4 Receptor (NCT00923390) | National Cancer Institute (NCI) | 2009-03-02 |
| A Comparison of Measurements of Ketone Body Flux Versus Ketone Body Concentration as a Pharmacodynamic Marker of Hepatic Fatty Acid Oxidation (0000-110) (NCT00860392) | Merck Sharp & Dohme LLC | 2009-03-02 |
| Study of Prasugrel in Korean Healthy Male Volunteers (NCT01591317) | Eli Lilly and Company | 2009-03-01 |
| Wavefront Analyzes and Visual Performance of Three Multifocal Intra-ocular Lenses (NCT00876707) | University of Sao Paulo | 2009-03-01 |
| Bioavailability of Dexmedetomidine After Intranasal Administration (NCT00837187) | University of Turku | 2009-03-01 |
| Lenalidomide and Decitabine in High Grade Myelodysplastic Syndromes (NCT00828802) | Duke University | 2009-03-01 |
| Comparison of the Action of Drugs in the Body and Safety of N8 and Advate® in Haemophilia A Subjects (NCT00837356) | Novo Nordisk A/S | 2009-03-01 |
| Visualization of the Effect of Acupuncture on Brain Serotonin in Breast Cancer Survivors (NCT01018108) | Abramson Cancer Center at Penn Medicine | 2009-03-01 |
| Phase I Study of TAK-701 in Adult Patients With Advanced Nonhematological Malignancies (NCT00831896) | Millennium Pharmaceuticals, Inc. | 2009-03-01 |
| Single-Dose Pharmacokinetics of BMS-790052 in Participants With Hepatic Impairment (NCT00859053) | Bristol-Myers Squibb | 2009-03-01 |
| Preoperative Chemotherapy With Paclitaxel, Gemcitabine, and Lapatinib (Tykerb®) (PGT) (NCT01133912) | Jungsil Ro | 2009-03-01 |
| A Dose-Finding Study of E7050 Administered Orally to Patients With Advanced Solid Tumors (NCT00869895) | Eisai Inc. | 2009-03-01 |
| AZD1981 Midazolam CYP4503A Induction Study (NCT00859352) | AstraZeneca | 2009-03-01 |
| Tumescent Antibiotic Delivery Pharmacokinetics (NCT01046981) | Klein, Jeffrey A., M.D. | 2009-03-01 |
| Pharmacokinetic Study of Single Doses of Clopidogrel, 75 mg and 300 mg, in Healthy Subjects (NCT01129063) | Sanofi | 2009-03-01 |
| Phase I/II Study of KRN330 Plus Irinotecan in Patients With Metastatic Colorectal Cancer (NCT00838578) | Kyowa Kirin Co., Ltd. | 2009-03-01 |
| Study of Biomarkers of Airway Inflammation (0000-128) (NCT00869596) | Merck Sharp & Dohme LLC | 2009-03-01 |
| QT Interval Prolongation Study of Eribulin Mesylate (E7389) in Patients With Advanced Solid Tumors (NCT01106248) | Eisai Limited | 2009-03-01 |
| A Phase 1 Dose Escalation Study of TAK-901 in Subjects With Advanced Hematologic Malignancies (NCT00807677) | Millennium Pharmaceuticals, Inc. | 2009-03-01 |